Aust manufacture of mental health psychedelics on the way

Meanwhile prominent therapist warns of potential limitations of MDMA and psilocybin therapy Leading international cannabis operation Virtura Health – known as the Amazon of medicinal cannabis – may begin manufacturing MDMA and psilocybin for the Australian market following a joint venture with Canadian operation PharmAla Biotech. The new company spawned by the JV, Cortexa, would

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Rural owners fume over 60-day dispensing impact analysis
Next ‘We needed this like a hole in the head’